Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows

v3.20.2
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash Flows from Operating Activities:    
Net loss $ (12,856) $ (15,888)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,095 2,444
Issuance of common shares - Founders Agreement 797 198
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 275 632
Other receivables - related party (2) 1,252
Accounts payable and accrued expenses (1,926) (5,282)
Net cash used in operating activities (11,617) (16,644)
Cash Flows from Financing Activities:    
Issuance of common shares - Public offering 20,500 0
Offering costs for the issuance of common shares - Public offering (1,361) 0
Proceeds from issuance of common stock - At-the-market offering 8,684 7,904
Offering costs for the issuance of common stock - At-the-market offering (267) (195)
Proceeds from the exercise or warrants 13 0
Net cash provided by financing activities 27,569 7,709
Net increase in cash and cash equivalents 15,952 (8,935)
Cash and cash equivalents at beginning of period 26,077 21,995
Cash and cash equivalents at end of period 42,029 13,060
Supplemental disclosure of noncash investing and financing activities:    
Issuance of common shares - Founders Agreement 2,510 1,748
Issuance of common shares - Public offering (offering costs incurred but not paid) $ 296 $ 0